The mean study population LVEF was 40.8±6.0%, WMSI 1.41±0.2 and RPSI 1.29±0.69. During 500 day follow-up 28 MACE were registered (8 deaths, 7 MI's, 13 rehospitalizations for CHF). Minimal NT-proBNP was 56,0, and maximal 8337,0 pg/ml. The ROC curve was constructed to assess cutoff point for MACE prediction during long-term follow-up. The best value to predict MACE was NT-proBNP over 1895 pg/ml (AUC 0,79). Based onNTproBNP(<or>1895 pg/ml) and rt-MCE results (MCE+ in 62 pts) the study population was divided into 4groups: group A (NTproBNP< and MCE-), group B (NTproBNP< and MCE+), group C (NT-proBNP> and MCE-) and group D (NTproBNP> and MCE+). According to survival analysis with Kaplana Meier method cumulative probability of MACE-free survival during 1.5 year follow-up was 35%, 78%, 91% and 98%, respectively. Conclusions: Combined use of discharge NT-proBNP and rt-MCE examination in patients with acute myocardial infarction treated with early PCI is simple and accurate predictor of major adverse cardiac events in long-term follow-up. Results: RFP was found in 14 patients (16%) at index evaluation. Patients with RFP had higher NYHA class, more frequently signs of heart failure and lower left ventricular ejection fraction (p=0.018, p=0.002 and p=0.001, respectively). During follow-up, mortality plus heart transplantation was significantly higher in HCM patients with RFP than in those without RFP (p=0.0001) (figure 1). NYHA class (HR=5.95, 95% CI: 1.34-26.38, p=0.019), indexed left atrial diameter (HR=1.68, 95% CI: 1.01-2.82, p=0.047) and RFP (HR=2.94, 95% CI: 1.25-6.88, p=0.01) were selected as predictors of death or transplant in a multivariate proportional hazard model. The AUC of ROC curve from multivariate regression models for predicting adverse outcome significantly improved from 0.76 considering only NYHA class to 0.84 after inclusion of RFP and indexed left atrial diameter (p=0.01). Conclusions: RFP is rare but not exceptional in HCM. Echo-Doppler evaluation of filling pattern confers additional prognostic power to clinical stratification.
with multivariate analysis, baseline gradients were lower (56±34 vs 66+34 mm Hg; p<0.05), and CK peaks higher (563±284 vs 490±248 U/l; p<0.05) in opt. results, however with a wide overlap. Age, septal thickness, functional class at baseline and at follow-up were comparable. No significant predictors were found for acc. results. Conclusions: In this carefully selected pt. cohort, hemodynamic response to PTSMA at 12 months of follow-up was not reliably predictable. Pts. who had a less favourable result at 3 months seemed to "catch up" during longerterm follow-up, consistent with the hypothesis of an ongoing local remodeling in the septal target region.
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Fabry heart disease: impact of enzyme replacement therapy on cardiac parameters in an observational long-term follow up study in 24 patients T. Kovacevic 
Zurich, Switzerland
Background: Fabry disease, a rare X-linked lysosomal storage disorder with deficient activity of ?-galactosidase A, causes cardiac disease including left ventricular hypertrophy (LVH), diastolic dysfunction, valvular heart disease ± arrhythmias. Enzyme replacement therapy (ERT) may improve echocardiographic parameters in Fabry patients (pt), however, data are limited. Methods: Prospective study in 24 pt with proven Fabry disease and long time ERT with i.v. agalsidase alfa or beta. All pt had complete echocardiographic examination (echo) prior ERT and at follow-up with analysis of systolic/diastolic function. Data from first and last exam were compared.
Results: There were 24 pt (18 men) (mean age of 42±13 years), who were treated for 30±14 months. 25% were hypertensive and 83% had acroparesthesia at the beginning. The median creatinine levels were 86mcmol/l (64-601) initially and 88 mcmol/l (67-624) at follow-up (p=ns). LVH was present in 12 pt (50%). In 17 of 20 pt (85%) there was increased echogeneicity in the posterior basal segments compatible with fibrosis. During ERT, acroparesthesia improved in 12 of 20 patients (60%). Echo changes during ERT are shown in the Table with ejection fraction (EF), left ventricular muscle mass index (LVMMI), left ventricular enddiastolic diameter(LVEDD) index, left atrial(LA) index, septum thickness, deceleration time of E-wave (Edec), E wave velocity over lateral annular E-wave velocity (E/E'), isovolumetric relaxation time (IVRT) and lateral annular E velocity (E') as mean ± SD (1 patient with aortic stenosis was excluded). In only 2 of 17 pt (12%) posterior fibrosis disappeared during ERT. Despite a borderline increase in the deceleration time of the E wave and decrease of the E/E' ratio, there was no significant change during follow-up. Conclusions: Our Fabry cohort had successful long time ERT with amelioration of subjective symptoms such as acroparesthesia, but we could not document regression of left ventricular muscle mass and only marginal changes of diastolic function during follow-up. ERT might have to be started prior cardiac damage occurs. The pressure gradient on the site of VSD and systolic pressure of the right ventricle (RVSP) were also measured.
Results: All patients were in NYHA III class, in sinus rhythm with average heart rate 86±18/min. LA and LV diameters were normal and average EF assessed by Simpson was decreased (32.9±7.5%). In 6 patients with inferior MI, VSD was located in the basal segment of the inferior LV wall, in 4 patients with anteroseptal MI at the site of interventricular septum and in 4 patients at the posterior wall of the LV. All patients had significant left-toright shunt whereas in 2 patients small right-to-left shunt also existed. Pressure gradient at the site of VSD was 75.25±27 mm Hg. All patients had mild MR and TR. RVSP was moderately increased (48.8±22.1 mm Hg). Dacron patch was placed on the VSD site in the majority of patients (12/14) with additional coronary artery by-pass grafting in 7 patients. In two patients direct suture was done. Haemodinamically insignificant residual shunt was detected immediately after operation in only two patients. One patient died immediately after operation and one 42 months after the operation.
Conclusion:
Patients with VSD after acute MI could be successfully surgically treated with good early as well as long term prognosis. Although these are high risk patients, in our study group surgical intervention was found to be justified and efficient treatment with good results. Echocardiography as non-invasive technique is a method of choice for early assessment for precise localization of the ruptured site and haemodinamic parameters as well as for early and late postoperative follow up.
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NT-proBNP in differentiation of normal and pseudonormal mitral flow in ischemic heart disease Echocardiographic assessment of LV diastolic function is important in settings of objective signs of heart failure in patients with preserved LV systolic function. Diagnosis of moderate diastolic dysfunction (DD) with pseudonormalization feature is difficult. The aim of the study was to assess NT-proBNP diagnostic value for diagnosis of DD and differentiation of normal and pseudonormal mitral flow. Methods: Among 83 consecutive patients /pts/ with angiographically documented coronary artery disease and LVEF>45% the normal mitral flow (E/A 1-2, DT >150-220 ms) was found in 40 pts (age 56+/-10 years, 33 males). In 32 of them the inflow from right superior pulmonary vein /RSPV/ was normal (S/D >1, Ar <35 cm/s)/groupA/and in 8 pts it was found to be pseudonormalized/ /groupB/. NT-proBNP was assessed in all pts. Results: LVEF was similar in both groups. In group B NT-proBNP levels were significantly higher (734+/-586 pg/ml vs 167+/-100; p<0,001/) than in group A. Based on the ROC curve the best discriminative value was >323 pg/ml (AUC 0,83, sensitivity 63%, specificity 97%, accuracy 85%, PPV 63%, NPV 90%).
Conclusions:
In ischemic heart disease with preserved LV systolic function and normal mitral flow NT-proBNP maybe helpful in selection of patients with isolated diastolic dysfunction and pseudonormal pattern of mitral flow. Increased levels of N-terminal pro brain natriuretic peptide (NT-proBNP) in non-ST segment elevation acute coronary syndromes (NSTE-ACS) have been related to elevated ventricular filling pressures due to myocardial ischemia, even on patients without heart failure. Analysis of echocardiographic parameters may be useful to show any relationship between NT-pro BNP elevation with systolic and/or diastolic ventricular dysfunction. Objectives: to detect any association between NT-proBNP and ventricular systolic and/or diastolic dysfunction in NSTE-ACS patients without heart failure. Methods: 70 NSTE-ACS patients (age=61±12 years, 65% men) without prior or in-hospital heart failure underwent transthoracic Doppler-echo and tissue Doppler (mitral and tricuspid annulus and basal segments of left ventricle) within 24 hours from last chest pain episode onset and within 1 hour of blood sampling for NT-proBNP measurement (Roche Elecsys 2010). Doppler-echo was performed according to standard guidelines, and the ratio between early diastolic mitral inflow velocity (E) and early diastolic mitral annular velocity (E´) was calculated (E/E´). NT-proBNP levels >80 pg/ml were considered as elevated (low cutoff values for patients without heart failure). Linear and logistic regression analysis were performed including the Doppler-echo parameters, and then including clinical, biochemical and ultrasonic variables. Results: 40 patients (57%) had elevated NT-proBNP. Doppler-echo variables associated to elevated NT-proBNP were left ventricular ejection fraction (LVEF, mean=0.56±11, p=0.002), fractional shortening (p=0.02), wall motion score index (p=0.048), LV mass (p=0.02), left atrial diameter (p=0.042), A mitral (p=0.044), systolic mitral annular velocity (p=0.02), E´ (p=0.001) and E/E( p=0.044). Multivariable analysis showed that the independent predictors of NT-ProBNP elevated were LVEF<55% (OR=6.78, 95% CI 1. p=0.008) and E´ velocity (OR=5.46, p=0.005) . Including other clinical and biochemical variables in the model, both ultrasonic variables persisted as independent predictors. Conclusion: In patients with non-ST segment elevation acute coronary syndromes, the increase in NT-proBNP levels is associated to both systolic and diastolic left ventricular dysfunction, even on patients without heart failure. Background: Fast and full restoration of infarct related artery patency did not mean achievement of tissue perfusion influencing remodeling process, adversely affecting left ventricular function. Aim of the study was to assess frequency, prognostic value and factors determining unfavorable remodeling. Material and methods: Consecutive 90 pts with first, only anterior wall myocardial infarction undergoing successful primary PCI were prospectively enrolled. Angiographic parameters: Rentrop scale, MBG, proximity of occlusion, electrocardiographic: maximal ST segment elevation from single lead, sum of ST segment elevations, and reduction of at least 50% of ST segment elevations 1hour after PCI. The next day echocardiographic assessment of left ventricular ejection fraction /LVEF/, end-diastolic volume /LVEDV/, perfusion contrast imaging to determine regional perfusion score index /RPSI/ were performed. Results: High correlation was found for maximum CK-MB and LVEDV at day 30 and 180 (r=0.71 and r=0.82). According to LVEDV increase >20% at 6-month follow-up study population was divided to group A 52 pts without unfavorable remodeling and group B 38 pts with it. Group A baseline LVEDV was 105,8 ml, group B 106 ml (p=ns), and RCSI 1.49 and 0.85 respectively (p<0.001). At 6-months group A LVEDV decreased to 99.1, and in group B increased to 156.1 (p<0.001). RPSI, proximal LAD occlusion, presence of S ST50% and CKMB value over cut-off value were significantly prognostic for remodeling.
Despite therapy according to current guidelines remodeling is present in significant proportion of pts with anterior MI. Among many established and well known electrocardiographic, angiographic and biochemical indices myocardial contrast echocardiography was found to have the highest remodeling prediction power.
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Role of myocardial performance index in prediction of postinfarction remodeling process 
